Table 2:
Patients with prescriptions for each RAASi class pre-index and at 180 days post-index (PS matched).
| USA | Japan | Spain | ||||
|---|---|---|---|---|---|---|
| Characteristic | SZC (n = 565) | No K+ binder (n = 2068) | SZC (n = 776) | No K+ binder (n = 2629) | SZC (n = 56) | No K+ binder (n = 203) |
| Pre-index | ||||||
| ACEi | 249 (44.1) | 913 (44.2) | 117 (15.1) | 391 (14.9) | 25 (44.6) | 96 (47.3) |
| ARB | 265 (46.9) | 998 (48.3) | 610 (78.6) | 2069 (78.7) | 28 (50.0) | 99 (48.8) |
| ARNi | 40 (7.1) | 136 (6.6) | 57 (7.4) | 190 (7.2) | 4 (7.1) | 15 (7.4) |
| MRA | 78 (13.8) | 259 (12.5) | 145 (18.7) | 467 (17.8) | 11 (19.6) | 41 (20.2) |
| Post-index | ||||||
| ACEi | 189 (33.5) | 540 (26.1) | 95 (12.2) | 231 (8.8) | 18 (32.1) | 65 (32.0) |
| ARB | 212 (37.5) | 656 (31.7) | 515 (66.4) | 1261 (48.0) | 25 (44.6) | 61 (30.0) |
| ARNi | 41 (7.3) | 104 (5.0) | 110 (14.2) | 196 (7.5) | 4 (7.1) | 10 (4.9) |
| MRA | 57 (10.1) | 129 (6.2) | 129 (16.6) | 270 (10.3) | 10 (17.9) | 21 (10.3) |
Values are presented as n (%).